M&A Deal Summary

The PharmEase Group Acquires Compound Preferred

On July 23, 2020, The PharmEase Group acquired life science company Compound Preferred

Acquisition Highlights
  • This is The PharmEase Group’s 1st transaction in the Life Science sector.
  • This is The PharmEase Group’s 1st transaction in the United States.
  • This is The PharmEase Group’s 1st transaction in Idaho.

M&A Deal Summary
Date 2020-07-23
Target Compound Preferred
Sector Life Science
Buyer(s) The PharmEase Group
Deal Type Add-on Acquisition

Target

Compound Preferred

Idaho Falls, Idaho, United States
Compound Preferred is specialize in cGMP Compounding, Outsourcing Facility. Compound Preferred is based in Idaho Falls, Idaho.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

The PharmEase Group

Ammon, Idaho, United States
Category Company
Founded 2001
Sector Life Science
DESCRIPTION

The PharmEase Group is comprised of multiple companies including Heartland Long Term Care Pharmacy and Compound Preferred. The PharmEase Group was founded in 2001 and is based in Ammon, Idaho.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Idaho) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
Mergr

Product

Company

Legal